Metabolic Mind | Are GLP1s Ozempic and Wegovy Safe in Psychiatry? @metabolicmind | Uploaded October 2023 | Updated October 2024, 38 minutes ago.
Wegovy, Ozempic, and other GLP1 weight loss drugs are increasingly being used for patients with psychiatric diagnoses like bipolar disorder, depression, or schizophrenia. However, there are safety concerns, with the potential for an increase in suicidal thoughts. Fortunately, other alternatives exist for combatting medication-induced weight gain, such as ketogenic therapy, which has also been shown to treat the underlying psychiatric condition. And yet, some have reported improved anxiety or depression after taking these medications. How do we decide if these medications are safe for people with a psychiatric diagnosis?
Reuter’s article:
reuters.com/business/healthcare-pharmaceuticals/us-psychiatrists-prescribe-wegovy-battle-medication-induced-weight-gain-2023-08-03
Here’s a news report from CNN covering the potential increased suicide risk.
cnn.com/2023/07/10/health/weight-loss-medications-under-evaluation-for-suicide-risks/index.html
Video with Dr. David Ludwig referenced in this video:
youtube.com/watch?v=SWbWYnHe6b4
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
About us:
Metabolic Mind™ is a nonprofit initiative incubated by Baszucki Group. Our mission is to provide education and resources in the emerging field of metabolic psychiatry, including ketogenic interventions for mental disorders.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
Time stamps:
0:00 Are Wegovy and Ozempic Safe?
00:30 Psychiatric diagnosis increases risk of metabolic and heart disease
1:20 Studies of Wegovy and Ozempic excluded psychiatric diagnoses
1:35 Possible increase in suicidal thoughts from Wegovy and other GLP1a
2:22 Ketogenic therapy can improve metabolic health and psychiatric symptoms
3:11 Scientific presentations about ketogenic therapy in psychiatry
3:44 Does keto increase risk of heart attacks?
4:38 Interview series of GLP1s in psychiatry
5:08 Wegovy, Ozempic and other LP1s should be used together with lifestyle changes
#MetabolicMind
#KetoForMentalHealth
#MetabolicPsychiatry
#BipolarTreatment
#MetabolicNeuroscience
#KetogenicMetabolicTherapy
#NutritionalKetosis
#MentalIllness
#BipolarDiet
#GLP1
#Ozempic
#Wegovy
#Suicide
Wegovy, Ozempic, and other GLP1 weight loss drugs are increasingly being used for patients with psychiatric diagnoses like bipolar disorder, depression, or schizophrenia. However, there are safety concerns, with the potential for an increase in suicidal thoughts. Fortunately, other alternatives exist for combatting medication-induced weight gain, such as ketogenic therapy, which has also been shown to treat the underlying psychiatric condition. And yet, some have reported improved anxiety or depression after taking these medications. How do we decide if these medications are safe for people with a psychiatric diagnosis?
Reuter’s article:
reuters.com/business/healthcare-pharmaceuticals/us-psychiatrists-prescribe-wegovy-battle-medication-induced-weight-gain-2023-08-03
Here’s a news report from CNN covering the potential increased suicide risk.
cnn.com/2023/07/10/health/weight-loss-medications-under-evaluation-for-suicide-risks/index.html
Video with Dr. David Ludwig referenced in this video:
youtube.com/watch?v=SWbWYnHe6b4
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
About us:
Metabolic Mind™ is a nonprofit initiative incubated by Baszucki Group. Our mission is to provide education and resources in the emerging field of metabolic psychiatry, including ketogenic interventions for mental disorders.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
Time stamps:
0:00 Are Wegovy and Ozempic Safe?
00:30 Psychiatric diagnosis increases risk of metabolic and heart disease
1:20 Studies of Wegovy and Ozempic excluded psychiatric diagnoses
1:35 Possible increase in suicidal thoughts from Wegovy and other GLP1a
2:22 Ketogenic therapy can improve metabolic health and psychiatric symptoms
3:11 Scientific presentations about ketogenic therapy in psychiatry
3:44 Does keto increase risk of heart attacks?
4:38 Interview series of GLP1s in psychiatry
5:08 Wegovy, Ozempic and other LP1s should be used together with lifestyle changes
#MetabolicMind
#KetoForMentalHealth
#MetabolicPsychiatry
#BipolarTreatment
#MetabolicNeuroscience
#KetogenicMetabolicTherapy
#NutritionalKetosis
#MentalIllness
#BipolarDiet
#GLP1
#Ozempic
#Wegovy
#Suicide
